Hikari Power Ltd reduced its stake in Nutrien Ltd. (NYSE:NTR – Free Report) by 80.0% in the 3rd quarter, Holdings Channel reports. The firm owned 30,000 shares of the company’s stock after selling 120,000 shares during the quarter. Nutrien accounts for approximately 0.5% of Hikari Power Ltd’s portfolio, making the stock its 14th biggest position. Hikari Power Ltd’s holdings in Nutrien were worth $2,108,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Vise Technologies Inc. boosted its position in shares of Nutrien by 5.7% in the third quarter. Vise Technologies Inc. now owns 13,162 shares of the company’s stock worth $925,000 after buying an additional 707 shares during the period. Oppenheimer & Co. Inc. raised its holdings in shares of Nutrien by 65.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 8,462 shares of the company’s stock valued at $594,000 after buying an additional 3,340 shares during the period. Apollon Wealth Management LLC purchased a new stake in shares of Nutrien during the 3rd quarter valued at about $409,000. Townsend & Associates Inc lifted its position in Nutrien by 0.6% during the 3rd quarter. Townsend & Associates Inc now owns 629,120 shares of the company’s stock worth $44,831,000 after acquiring an additional 3,645 shares in the last quarter. Finally, Signaturefd LLC lifted its position in Nutrien by 8.8% during the 3rd quarter. Signaturefd LLC now owns 15,580 shares of the company’s stock worth $1,095,000 after acquiring an additional 1,255 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Stock Down 1.5%
Shares of NYSE NTR opened at $69.18 on Wednesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. Nutrien Ltd. has a 1 year low of $53.03 and a 1 year high of $85.36. The stock’s 50-day simple moving average is $72.94 and its 200-day simple moving average is $71.04. The firm has a market cap of $32.88 billion, a price-to-earnings ratio of 14.00, a PEG ratio of 0.78 and a beta of 0.67.
Nutrien (NYSE:NTR – Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). The business had revenue of $10.81 billion during the quarter, compared to analyst estimates of $10.44 billion. Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the previous year, the company earned $2.65 earnings per share. As a group, equities analysts anticipate that Nutrien Ltd. will post 4.53 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on NTR. Mizuho decreased their price target on Nutrien from $77.00 to $75.00 and set a “neutral” rating for the company in a report on Tuesday, July 14th. Canadian Imperial Bank of Commerce reiterated an “outperform” rating on shares of Nutrien in a research note on Monday, August 10th. Weiss Ratings lowered shares of Nutrien from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, October 19th. National Bank Financial reduced their target price on shares of Nutrien from $76.00 to $74.00 and set an “outperform” rating on the stock in a research report on Monday, August 10th. Finally, BNP Paribas Exane raised shares of Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 target price on the stock in a research report on Tuesday, July 28th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Nutrien currently has an average rating of “Moderate Buy” and an average target price of $79.24.
Read Our Latest Research Report on NTR
Nutrien Company Profile
Read More
- Five stocks we like better than Nutrien
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR – Free Report).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
